vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $77.6M, roughly 1.9× Bioceres Crop Solutions Corp.). On growth, STURM RUGER & CO INC posted the faster year-over-year revenue change (3.6% vs -16.8%). Over the past eight quarters, STURM RUGER & CO INC's revenue compounded faster (5.1% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
BIOX vs RGR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $151.1M |
| Net Profit | $-7.4M | — |
| Gross Margin | 46.8% | 17.8% |
| Operating Margin | 9.3% | 2.3% |
| Net Margin | -9.6% | — |
| Revenue YoY | -16.8% | 3.6% |
| Net Profit YoY | -20.2% | — |
| EPS (diluted) | $-0.12 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $151.1M | ||
| Q3 25 | $77.6M | $126.8M | ||
| Q2 25 | — | $132.5M | ||
| Q1 25 | $60.6M | $135.7M | ||
| Q4 24 | $98.8M | $145.8M | ||
| Q3 24 | $93.3M | $122.3M | ||
| Q2 24 | — | $130.8M | ||
| Q1 24 | $84.0M | $136.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-7.4M | $1.6M | ||
| Q2 25 | — | $-17.2M | ||
| Q1 25 | $-1.6M | $7.8M | ||
| Q4 24 | $605.2K | — | ||
| Q3 24 | $-6.2M | $4.7M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | $9.8M | $7.1M |
| Q4 25 | — | 17.8% | ||
| Q3 25 | 46.8% | 15.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | 39.4% | 22.0% | ||
| Q4 24 | 42.0% | 22.8% | ||
| Q3 24 | 40.2% | 18.5% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | 50.8% | 21.5% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | 9.3% | -2.7% | ||
| Q2 25 | — | -15.6% | ||
| Q1 25 | 1.5% | 6.2% | ||
| Q4 24 | 14.5% | 7.8% | ||
| Q3 24 | 2.5% | 3.1% | ||
| Q2 24 | — | 6.9% | ||
| Q1 24 | 15.7% | 5.5% |
| Q4 25 | — | — | ||
| Q3 25 | -9.6% | 1.2% | ||
| Q2 25 | — | -13.0% | ||
| Q1 25 | -2.6% | 5.7% | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | -6.6% | 3.9% | ||
| Q2 24 | — | 6.3% | ||
| Q1 24 | 11.6% | 5.2% |
| Q4 25 | — | $0.22 | ||
| Q3 25 | $-0.12 | $0.10 | ||
| Q2 25 | — | $-1.05 | ||
| Q1 25 | $-0.02 | $0.46 | ||
| Q4 24 | $0.00 | $0.62 | ||
| Q3 24 | $-0.10 | $0.28 | ||
| Q2 24 | — | $0.47 | ||
| Q1 24 | $0.14 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $92.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $288.3M | $283.8M |
| Total Assets | $734.9M | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.5M | ||
| Q3 25 | $15.5M | $80.8M | ||
| Q2 25 | — | $101.4M | ||
| Q1 25 | $38.5M | $108.3M | ||
| Q4 24 | $29.2M | $105.5M | ||
| Q3 24 | $32.3M | $96.0M | ||
| Q2 24 | — | $105.6M | ||
| Q1 24 | $16.4M | $115.3M |
| Q4 25 | — | $283.8M | ||
| Q3 25 | $288.3M | $279.6M | ||
| Q2 25 | — | $289.3M | ||
| Q1 25 | $345.0M | $321.5M | ||
| Q4 24 | $346.3M | $319.6M | ||
| Q3 24 | $346.0M | $314.9M | ||
| Q2 24 | — | $321.5M | ||
| Q1 24 | $348.5M | $332.0M |
| Q4 25 | — | $342.0M | ||
| Q3 25 | $734.9M | $342.3M | ||
| Q2 25 | — | $349.5M | ||
| Q1 25 | $798.2M | $379.0M | ||
| Q4 24 | $835.2M | $384.0M | ||
| Q3 24 | $827.3M | $373.5M | ||
| Q2 24 | — | $376.7M | ||
| Q1 24 | $836.1M | $385.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $15.5M |
| Free Cash FlowOCF − Capex | — | $12.3M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $15.5M | ||
| Q3 25 | $14.4M | $12.9M | ||
| Q2 25 | — | $14.7M | ||
| Q1 25 | $23.3M | $11.1M | ||
| Q4 24 | $-5.4M | $20.0M | ||
| Q3 24 | $5.2M | $9.4M | ||
| Q2 24 | — | $18.7M | ||
| Q1 24 | $-17.4M | $7.3M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | — | $7.0M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $10.0M | ||
| Q4 24 | — | $16.4M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 7.7% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | -1.78× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
